Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Sum of short-term and long-term debt obligations
3Y CAGR
+15.2%/yr
Annual compound
5Y CAGR
+37.9%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
5x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $77.97M | -28.1% |
| 2024 | $108.49M | +114.1% |
| 2023 | $50.67M | -0.7% |
| 2022 | $51.01M | +344.4% |
| 2021 | $11.48M | -26.7% |
| 2020 | $15.66M | -3.1% |
| 2019 | $16.17M | - |